Kevin Slavin

New York based biosecurity strategist working at the intersection of science, technology and communication. Co-founder of Fairfield Bio, a pandemic-response lead at the onset of COVID-19, and previously the founder of a research group at MIT, he focuses on how we detect and contain pathogens before they become outbreaks. He brings the biosecurity perspective: how a virus actually moves, what is worth watching, and how to keep concern calibrated rather than alarmed.

Involved in:

• One Basin CRC: A Bird’s Eye View of H5N1 (August 2026)